Advances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction

With the gradual prolongation of the overall survival of cancer patients, the cardiovascular toxicity associated with oncology drug therapy and radiotherapy has attracted increasing attention. At present, the main methods to identify early cancer treatment-related cardiac dysfunction (CTRCD) include...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Huiyu, Wang, Xiaojie, Li, Shuang, Liu, Ying, Cui, Yijie, Deng, Xiaoqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631401/
https://www.ncbi.nlm.nih.gov/pubmed/34859069
http://dx.doi.org/10.3389/fcvm.2021.753313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631401/
https://www.ncbi.nlm.nih.gov/pubmed/34859069
http://dx.doi.org/10.3389/fcvm.2021.753313

Ejemplares similares